Pfizer has initiated a US only
recall of one lot of 30-count
Effexor XR (venlafaxine HCl) 150
mg extended-release capsules,
one lot of 90-count Effexor XR
(venlafaxine HCl) 150 mg extendedrelease
capsules and one lot of
90-count Greenstone LLC-branded
Venlafaxine HCl 150 mg extendedrelease
capsules.
According to Business Wire, the
recall was undertaken because of a
pharmacist report that one bottle
of Pfizer’s Effexor XR contained
one capsule of Tikosyn (dofetilide)
0.25mg in addition to the Effexor XR
capsules, each batch of which was
assembled on the same line.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Mar 14
PATIENTS who legitimately need compounded Ozempic should still have access to the medication, even if a government ban comes into effect, advises the Consumers Health Forum of Australia (CHF).
QUEENSLAND pharmacists can commence their full scope of practice journey with the newly launched Prescribing Hormonal Contraceptives Course by the Australasian College of Pharmacy.
A SURGE in international and local demand has led to complementary medicines becoming a huge success story for Australia, according to peak body Complementary Medicines Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.